ARTICLE | Company News
Peg-Intron approved for hepatitis C in U.S.
January 22, 2001 8:00 AM UTC
Schering-Plough (SGP) said that its Peg-Intron pegylated interferon-alpha-2b powder for injection received FDA approval as monotherapy to treat chronic hepatitis C in patients who have not been previo...